Intrinsic Value of S&P & Nasdaq Contact Us

InMode Ltd. INMD NASDAQ

NASDAQ Global Select • Healthcare • Medical - Devices • IL • USD

SharesGrow Score
68/100
4/7 Pass
SharesGrow Intrinsic Value
$24.89
+76%
Analyst Price Target
$16.00
+13.2%
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

InMode Ltd. (INMD) trades at a trailing P/E of 9.3, forward P/E of 9.8. Trailing earnings yield is 10.77%, forward earnings yield 10.21%. PEG 9.79. Graham Number is $18.96.

Criteria proven by this page:

  • VALUE (74/100, Pass) — P/E is below market average (9.3); analyst target implies upside (+13.2%); earnings yield beats bond yields (10.77%).
  • PEG Ratio 9.79 — above 2.0 suggests expensive relative to earnings growth.
  • Trailing Earnings Yield 10.77% — exceeds typical bond yields (~4.3%), making equity attractive vs fixed income.
  • Analyst consensus target $16.00 (+13.2% upside) — modest upside expected.

Overall SharesGrow Score: 68/100 with 4/7 criteria passed.

SharesGrow 7-Criteria Score
68/100
SG Score
View full scorecard →
VALUE
74/100
Price-to-Earnings & upside
Proven by this page
~
FUTURE
52/100
Analyst consensus
→ Forecast
PAST
100/100
→ Income
HEALTH
100/100
Debt-to-Equity & liquidity
→ Health
~
MOAT
49/100
→ Income
GROWTH
15/100
→ Income
INCOME
85/100
→ Income

Valuation Snapshot — INMD

Valuation Multiples
P/E (TTM)9.3
Forward P/E9.8
PEG Ratio9.79
Forward PEG9.79
P/B Ratio1.28
P/S Ratio2.35
EV/EBITDA5.6
Per Share Data
EPS (TTM)$1.48
Forward EPS (Est.)$1.44
Book Value / Share$10.79
Revenue / Share$5.85
FCF / Share$1.41
Yields & Fair Value
Earnings Yield10.77%
Forward Earnings Yield10.21%
Dividend Yield0.00%
Graham Number$18.96
SharesGrow IV$24.89 (+76%)
Analyst Target$16.00 (+13.2%)

Historical Valuation

Year P/E (TTM) PEG Ratio P/B Ratio P/S Ratio Dividend Yield
2016 1,212.5 0.00 45.67 17.65 -
2017 49.2 0.02 22.32 8.12 -
2018 19.4 0.13 10.04 4.33 -
2019 18.7 0.09 6.51 7.33 -
2020 22.8 -23.96 6.74 8.31 -
2021 34.8 0.37 13.82 16.08 -
2022 18.2 -5.29 5.31 6.48 -
2023 9.4 0.45 2.36 3.78 -
2024 7.3 -2.16 1.88 3.35 -
2025 10.1 -0.28 1.39 2.56 -

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2016 $0.01 $23.08M $336K 1.5%
2017 $0.14 $53.46M $8.82M 16.5%
2018 $0.35 $100.16M $22.37M 22.3%
2019 $0.80 $156.36M $61.15M 39.1%
2020 $0.89 $206.11M $75.03M 36.4%
2021 $1.92 $357.57M $164.97M 46.1%
2022 $1.89 $454.27M $161.52M 35.6%
2023 $2.30 $492.05M $197.92M 40.2%
2024 $2.25 $394.82M $181.28M 45.9%
2025 $1.43 $370.5M $93.83M 25.3%

Analyst Estimates

Year EPS (Avg) EPS Range Revenue (Avg) Revenue Range Analysts
2026 $1.44 $1.43 – $1.45 $369.63M $366.92M – $371.63M 4
2027 $1.53 $1.37 – $1.63 $381.26M $374.45M – $386.81M 5
2028 $1.52 $1.51 – $1.53 $384.3M $381.49M – $386.38M 1
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message